These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29351138)

  • 1. The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program (M-PAWS): A Randomized, Double-blind, Placebo-controlled Trial.
    Bondi CD; Kamal KM; Johnson DA; Witt-Enderby PA; Giannetti VJ
    J Addict Med; 2018; 12(3):201-206. PubMed ID: 29351138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study.
    Garzón C; Guerrero JM; Aramburu O; Guzmán T
    Aging Clin Exp Res; 2009 Feb; 21(1):38-42. PubMed ID: 19225268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-detoxification drug treatment of anxiety and depression in alcohol addicts.
    Hague WH; Wilson LG; Dudley DL; Cannon DS
    J Nerv Ment Dis; 1976 May; 162(5):354-9. PubMed ID: 772172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.
    Chen WY; Giobbie-Hurder A; Gantman K; Savoie J; Scheib R; Parker LM; Schernhammer ES
    Breast Cancer Res Treat; 2014 Jun; 145(2):381-8. PubMed ID: 24718775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroacupuncture for tapering off long-term benzodiazepine use: A randomized controlled trial.
    Yeung WF; Chung KF; Zhang ZJ; Zhang SP; Chan WC; Ng RM; Chan CL; Ho LM; Yu BY; Chau JC; Lau NC; Lao LX
    J Psychiatr Res; 2019 Feb; 109():59-67. PubMed ID: 30504097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.
    Lähteenmäki R; Puustinen J; Vahlberg T; Lyles A; Neuvonen PJ; Partinen M; Räihä I; Kivelä SL
    Br J Clin Pharmacol; 2014 Jun; 77(6):975-85. PubMed ID: 24286360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
    Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
    Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.
    Kayumov L; Brown G; Jindal R; Buttoo K; Shapiro CM
    Psychosom Med; 2001; 63(1):40-8. PubMed ID: 11211063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study.
    Srisurapanont M; Jarusuraisin N
    Acta Psychiatr Scand; 1998 Mar; 97(3):233-5. PubMed ID: 9543313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.